Cargando…
Inclusion of premenopausal women in breast cancer clinical trials
BACKGROUND: Patients with premenopausal breast cancer (PMBC) have been historically excluded from some clinical trials because of the limitations of using endocrine therapy (ET) in this population. We analyzed breast cancer randomized clinical trials (RCTs) to determine the rates of and factors asso...
Autores principales: | Corrigan, Kelsey L., Kouzy, Ramez, Jaoude, Joseph Abi, Patel, Roshal R., Layman, Rachel M., Giordano, Sharon H., Woodward, Wendy A., Smith, Benjamin D., Shaitelman, Simona F., Ludmir, Ethan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637813/ https://www.ncbi.nlm.nih.gov/pubmed/36327626 http://dx.doi.org/10.1016/j.breast.2022.10.013 |
Ejemplares similares
-
Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020) -
Impact factor and citation metrics in phase III cancer trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021) -
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Applying to Radiation Oncology Amid a Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020)